Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatologic prescriptions requiring compounding.

M C Smith, A H Kibbe, T R Brown

    Journal of the American Academy of Dermatology
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oxycodone hydrochloride immediate-release analgesic for managing severe pain: abuse-deterrent formulations.

    Therapeutics and clinical risk management·2018
    Same author

    An in vitro method of evaluating tolnaftate release from topical powder.

    Pharmaceutical research·2013
    Same author

    Using rotifer population demographic parameters to assess impacts of the degradation products from trinitrotoluene phytoremediation.

    Ecotoxicology and environmental safety·2003
    Same author

    Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.

    European heart journal·2003
    Same author

    Refinement of the nickel site structure in Desulfovibrio gigas hydrogenase using range-extended EXAFS spectroscopy.

    Journal of inorganic biochemistry·2003
    Same author

    'See and treat' at colposcopy--achieving the standard.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2003
    Same journal

    Highlights from JAAD Case Reports: September 2026: Repurposing established therapies through biologic insight.

    Journal of the American Academy of Dermatology·2026
    Same journal

    First-Come, First-Served: Ethics of Coordinated Interview Releases.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Ethical Implications of Integrating Artificial Intelligence Tools into Dermatology Electronic Health Records.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Real-world experience with extended deucravacitinib-biologic combination therapy in refractory psoriasis and psoriatic arthritis.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'

    Journal of the American Academy of Dermatology·2026
    See all related articles

    Dermatologists frequently compound prescriptions using an average of 2.5 ingredients, most commonly anti-inflammatory agents. Brand-name drugs are often included in these compounded formulations.

    Area of Science:

    • Dermatology
    • Pharmaceutical Sciences
    • Compounding Pharmacy

    Background:

    • Compounding is a vital service in dermatology, allowing for customized patient treatments.
    • Understanding the common ingredients and trends in dermatological compounding is essential for pharmacists and physicians.

    Purpose of the Study:

    • To analyze the types and frequency of ingredients used in dermatological prescriptions requiring compounding.
    • To identify common trends in compounded prescriptions, including the use of brand-name medications.

    Main Methods:

    • A mail survey was distributed to dermatologists.
    • Dermatologists provided 520 examples of prescriptions that required compounding.
    • Data on ingredients and prescription characteristics were collected and analyzed.

    Related Experiment Videos

    Main Results:

    • A total of 520 compounded prescriptions were analyzed.
    • 195 distinct ingredients were identified across the prescriptions.
    • The average number of ingredients per prescription was 2.5.
    • Anti-inflammatory agents were the most frequently utilized ingredient class.
    • Brand-name medications were commonly incorporated into compounded prescriptions.

    Conclusions:

    • Compounded dermatological prescriptions often involve multiple ingredients, with a prevalence of anti-inflammatory agents.
    • The inclusion of brand-name drugs in compounding highlights a need for careful formulation and cost considerations.